Methylnaltrexoneiodide, a quaternary derivative of Naltrexone, is an orally active and selective antagonist of the mu-opioid receptor. It acts peripherally in the gastrointestinal tract to antagonize the receptor. Furthermore, Methylnaltrexoneiodide exhibits limited permeability across the blood-brain barrier.